Novo Nordisk announced a direct-to-consumer program that allows patients to buy Wegovy out of pocket at a lower cost.

Europe’s largest pharmaceutical firm, Novo Nordisk, has announced that it will offer its most popular weight-loss drug, Wegovy ... Under US Food and Drug Administration (FDA) policy, compounding ...

The makers of two popular weight-loss drugs—Wegovy and Zepbound—are cutting prices to make the medications more affordable for people without insurance. Novo Nordisk, the Danish company behind Wegovy, ...

Novo Nordisk’s weight loss drug Wegovy is linked to an increased risk of hair loss, a study suggests. Meanwhile, Dexcom ...

Adults with obesity who have a prescription for Wegovy but do not have insurance coverage for the drug can now purchase the ...

The end of compounded versions of weight-loss drugs is near, leaving patients scrambling for alternatives. Some “copycat” ...

Weight-loss drugs, including Ozempic and Wegovy, could cost more. Generic meds could also see price increases and perhaps shortages, he added. Users of revolutionary weight-loss drugs may have to ...

Now, the company is adding the 7.5 mg and 10 mg vials. And on Wednesday the maker of Wegovy, a similar weight-loss drug, announced that it, too, would offer direct-to-consumer discounts for ...

(Reuters) -The U.S. Food and Drug Administration said on Monday it will not take action against compounding pharmacies making copies of Novo Nordisk (NYSE:NVO)’s weight-loss drug Wegovy until a ...

Weight-loss jabs have become so popular that a quick rummage inside any midlife woman's fridge might be enough to reveal an injection pen nestling alongside the sugar-free yoghurts and diet drinks.